Literature DB >> 893266

Time course of pulmonary vascular response to microembolization.

A B Malik, H van der Zee.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 893266     DOI： 10.1152/jappl.1977.43.1.51

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN： 0161-7567


× No keyword cloud information.
  9 in total

Review 1.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

2.  Single versus multiple pulmonary emboli: different haemodynamic and blood gas results.

Authors:  J C Kay; W H Noble; Y Z Kadiri
Journal:  Can Anaesth Soc J       Date:  1981-11

Review 3.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

4.  Scintigraphic analysis as a diagnostic tool in canine experimental lung embolism.

Authors:  C Clercx; W E van den Brom; T S van den Ingh; H W de Vries
Journal:  Lung       Date:  1989       Impact factor: 2.584

5.  Pulmonary embolism distribution to ventilated and unventilated lungs in the dog: a cause of hypoxaemia.

Authors:  Y Z Kadiri; J C Kay; K Kovacs; W H Noble
Journal:  Can Anaesth Soc J       Date:  1980-05

6.  Cardiovascular changes after pulmonary cement embolism: an experimental study in sheep.

Authors:  J Krebs; N Aebli; B G Goss; K Wilson; R Williams; S J Ferguson
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

Review 7.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 8.  Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome.

Authors:  Robert MacLaren; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705

Review 9.  Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.

Authors:  Alba B Souza-Fernandes; Paolo Pelosi; Patricia R M Rocco
Journal:  Crit Care       Date:  2006       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.